RYH
|
|
|
Guggenheim S&P 500® Equal Weight Health Care ETF
|
|
|
NAV $95.55
Change $0.09 | 0.09%
As Of 5/23/13
|
Investment Objectives
Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.
Net Asset Value
|
Net Asset Value
|
$95.55
|
|
Change
|
$0.09
| 0.09%
|
Summary
|
Ticker
|
RYH
|
|
CUSIP
|
78355W841
|
|
Asset Class
|
Sector
|
|
Inception Date
|
11/1/06
|
|
Gross Expense Ratio
|
0.50%
|
|
IOPV Ticker
|
RYH.IV
|
|
Related Index Ticker
|
S35
|
| Investment Adviser |
Security Investors, LLC.
|
| Distributor |
Rydex Distributors, LLC.
|
Profile
|
Volume
|
4,611
|
|
Last Sale Price
|
$95.58
|
|
52-Week Range
|
$96.01
/ $69.68
|
|
Shares Outstanding
|
1,350,000
|
|
Total Net Assets
|
$128,985,986.51
|
|
Market Close
|
Market Price
|
$95.58
|
| Premium / Discount |
$0.03
|
|
Change
|
$0.10
| 0.10%
|
|
High / Low
|
$95.74
/ $94.73
|
Historical Market Closes to NAV
|
|
Days
|
% of Total Days
|
| Premium |
778
|
47.18%
|
| Discount |
778
|
47.18%
|
|
Equal to NAV
|
93
|
5.64%
|
|
Total
|
1,649
|
100%
|
Characteristics
|
Number of Stocks
|
53
|
|
Return on Equity (quarterly 3/28/13)
|
15.96%
|
|
Price to Earning (P/E)
|
24.89
|
|
Price to Book (P/B)
|
3.78
|
|
Dividend Amount
|
$0.08
|
|
Ex-Dividend Date
|
N/A
|
Risk
As of 4/30/13
|
Standard Deviation
|
Sharpe Ratio
|
Beta
|
R-Squared
|
|
14.15
|
1.16
|
1.01
|
99.61
|
|
Risk Definitions
|
Standard Deviation
|
A statistical measure of the historical volatility of an investment, computed using
36 monthly returns. More generally, a measure of the extent to which numbers are
spread around their average. The higher the number, the more volatility is to be
expected.
|
|
Sharpe Ratio
|
A risk-adjusted measure developed by William F. Sharpe, calculated using standard
deviation and excess return to determine reward per unit of risk. The higher the
Sharpe ratio, the better the fund's risk-adjusted performance.
|
|
Beta
|
Beta is a statistical measure of volatility relative to the overall market, usually
the S&P 500. A positive beta indicates movement in the same direction as the
market, while a negative beta indicates movement inverse to the market. Beta for
the market is generally considered to be 1. A beta above 1 or below -1 indicates
more volatility than the market. A beta between 1 to -1 indicates less volatility
than the market.
|
R-Squared
|
A measurement of how closely an investment's performance correlates with the performance
of a benchmark, such as the S&P 500, and thus a measurement of what portion
of its performance may be explained by the performance of the overall market or
index. Values for R-squared range from 0 to 100, where 0 indicates no correlation
and 100 indicates perfect correlation.
|
Overview
as of 5/23/2013
|
Total Assets
|
$128,985,987
|
|
Number of Stocks
|
53
|
|
Percent Stock
|
99.83%
|
|
Percent Cash / Other
|
0.17%
|
Sectors / Industries
as of 5/23/13
| Security Name |
Ticker |
Shares
Held |
Market
Value |
% of Net Assets |
Sector / Industry |
| Actavis |
ACT |
25,388 |
$3,251,695.04 |
2.52% |
Pharmaceuticals |
| BIOGEN IDEC, INC. |
BIIB |
12,894 |
$2,999,402.28 |
2.33% |
Biotechnology |
| REGENERON PHARMACEUTICALS |
REGN |
11,306 |
$2,881,560.22 |
2.23% |
Biotechnology |
| BRISTOL MYERS SQUIBB CO |
BMY |
59,447 |
$2,794,009.00 |
2.17% |
Pharmaceuticals |
|
ABBV |
59,535 |
$2,773,735.65 |
2.15% |
Pharmaceuticals |
| WELLPOINT, INC. |
WLP |
35,270 |
$2,750,354.60 |
2.13% |
Health Care Providers & Services |
| BOSTON SCIENTIFIC CORP |
BSX |
296,811 |
$2,718,788.76 |
2.11% |
Health Care Equipment & Supplies |
| GILEAD SCIENCES, INC. |
GILD |
48,931 |
$2,714,691.88 |
2.10% |
Biotechnology |
| LIFE TECHNOLOGIES CORP |
LIFE |
36,637 |
$2,708,939.78 |
2.10% |
Life Sciences Tools & Services |
| AETNA INC |
AET |
44,677 |
$2,698,044.03 |
2.09% |
Health Care Providers & Services |
| HUMANA, INC. |
HUM |
32,680 |
$2,609,171.20 |
2.02% |
Health Care Providers & Services |
| HOSPIRA INC |
HSP |
73,830 |
$2,597,339.40 |
2.01% |
Pharmaceuticals |
| UNITEDHEALTH GROUP INC. |
UNH |
41,317 |
$2,576,528.12 |
2.00% |
Health Care Providers & Services |
| CIGNA CORPORATION |
CI |
37,260 |
$2,530,699.20 |
1.96% |
Health Care Providers & Services |
| AMGEN INC. |
AMGN |
23,909 |
$2,525,268.58 |
1.96% |
Biotechnology |
| MEDTRONIC, INC. |
MDT |
48,754 |
$2,508,880.84 |
1.95% |
Health Care Equipment & Supplies |
| BECTON DICKINSON & CO |
BDX |
25,022 |
$2,506,453.74 |
1.94% |
Health Care Equipment & Supplies |
| LABORATORY CORP OF AMERIC |
LH |
24,854 |
$2,503,046.34 |
1.94% |
Health Care Providers & Services |
| AMERISOURCEBERGEN CORP |
ABC |
45,852 |
$2,502,602.16 |
1.94% |
Health Care Providers & Services |
| JOHNSON & JOHNSON |
JNJ |
28,434 |
$2,479,729.14 |
1.92% |
Pharmaceuticals |
| THERMO FISHER SCIENTIFIC |
TMO |
28,856 |
$2,472,670.64 |
1.92% |
Life Sciences Tools & Services |
| CELGENE CORPORATION |
CELG |
19,964 |
$2,468,348.96 |
1.91% |
Biotechnology |
| QUEST DIAGNOSTICS, INC. |
DGX |
39,738 |
$2,462,563.86 |
1.91% |
Health Care Providers & Services |
| MERCK & COMPANY, INC. |
MRK |
51,732 |
$2,448,475.56 |
1.90% |
Pharmaceuticals |
| ALEXION PHARMACEUTICALS I |
ALXN |
24,410 |
$2,438,070.80 |
1.89% |
Biotechnology |
| ABBOTT LABORATORIES |
ABT |
64,104 |
$2,402,617.92 |
1.86% |
Health Care Equipment & Supplies |
| PATTERSON COS INC |
PDCO |
60,325 |
$2,385,853.75 |
1.85% |
Health Care Providers & Services |
| MCKESSON CORPORATION |
MCK |
20,331 |
$2,384,419.68 |
1.85% |
Health Care Providers & Services |
| EXPRESS SCRIPTS HLDGS |
ESRX |
37,805 |
$2,377,178.40 |
1.84% |
Health Care Providers & Services |
| ST. JUDE MEDICAL INC. |
STJ |
52,622 |
$2,376,935.74 |
1.84% |
Health Care Equipment & Supplies |
| AGILENT TECHNOLOGIES, INC |
A |
51,665 |
$2,363,157.10 |
1.83% |
Life Sciences Tools & Services |
| ZIMMER HOLDINGS INC |
ZMH |
29,490 |
$2,357,725.50 |
1.83% |
Health Care Equipment & Supplies |
| DAVITA, INC |
DVA |
18,730 |
$2,351,738.80 |
1.82% |
Health Care Providers & Services |
| C.R. BARD, INC. |
BCR |
22,087 |
$2,322,448.05 |
1.80% |
Health Care Equipment & Supplies |
| CERNER CORPORATION |
CERN |
24,088 |
$2,322,324.08 |
1.80% |
Health Care Technology |
| FOREST LABORATORIES, INC. |
FRX |
58,658 |
$2,318,750.74 |
1.80% |
Pharmaceuticals |
| TENET HEALTHCARE CORP |
THC |
51,466 |
$2,315,970.00 |
1.80% |
Health Care Providers & Services |
| MYLAN INC. |
MYL |
72,341 |
$2,296,826.75 |
1.78% |
Pharmaceuticals |
| PFIZER INC |
PFE |
78,866 |
$2,295,789.26 |
1.78% |
Pharmaceuticals |
| BAXTER INTERNATIONAL |
BAX |
31,813 |
$2,295,307.95 |
1.78% |
Health Care Equipment & Supplies |
| WATERS CORPORATION |
WAT |
23,531 |
$2,286,507.27 |
1.77% |
Life Sciences Tools & Services |
| CAREFUSION CORP |
CFN |
66,438 |
$2,286,131.58 |
1.77% |
Health Care Equipment & Supplies |
| STRYKER CORP |
SYK |
33,825 |
$2,274,393.00 |
1.76% |
Health Care Equipment & Supplies |
| CARDINAL HEALTH, INC. |
CAH |
48,042 |
$2,266,141.14 |
1.76% |
Health Care Providers & Services |
| PERRIGO COMPANY |
PRGO |
19,218 |
$2,265,033.48 |
1.76% |
Pharmaceuticals |
| COVIDIEN PLC |
COV |
34,114 |
$2,224,573.94 |
1.72% |
Health Care Equipment & Supplies |
| ELI LILLY & COMPANY |
LLY |
40,305 |
$2,206,295.70 |
1.71% |
Pharmaceuticals |
| DENTSPLY INTERNATIONAL |
XRAY |
52,010 |
$2,158,935.10 |
1.67% |
Health Care Equipment & Supplies |
| INTUITIVE SURGICAL, INC. |
ISRG |
4,324 |
$2,068,861.04 |
1.60% |
Health Care Equipment & Supplies |
| VARIAN MEDICAL SYSTEMS IN |
VAR |
30,113 |
$2,044,371.57 |
1.58% |
Health Care Equipment & Supplies |
| ALLERGAN INC |
AGN |
20,308 |
$1,989,371.68 |
1.54% |
Pharmaceuticals |
| PERKINELMER |
PKI |
62,515 |
$1,985,476.40 |
1.54% |
Life Sciences Tools & Services |
| EDWARDS LIFESCIENCES CORP |
EW |
24,621 |
$1,618,092.12 |
1.25% |
Health Care Equipment & Supplies |
| SSGA FUNDS SSGA GOVERNMENT MONEY MARKET |
|
183,869 |
$183,868.69 |
0.14% |
na |
|
|
Disclosure
Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.
Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.
Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.
Fund data is subject to change on a daily basis.
Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.
“Standard & Poor’s®”, “S&P®”, “S&P 500®”, “Standard & Poor’s 500”, “500”, “S&P MidCap 400” and “S&P SmallCap 600” are trademarks of Standard & Poor’s, LLC and have been licensed for use by Guggenheim Investments and its affiliates. Citigroup is a trademark of Citigroup Global Markets Inc. and has been licensed for use by Standard & Poor’s. The product is not sponsored, endorsed, sold or promoted by Standard & Poor’s, and neither Standard & Poor’s nor Citigroup Global Markets Inc. makes no representation regarding the advisability of investing in the product.
|
|
2013 Guggenheim Investments. All Rights Reserved.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.
Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC (“GP”), which includes Security Investors, LLC (“SI”), Guggenheim Funds Investment Advisors, LLC (“GFIA”) and Guggenheim Partners Investment Management (“GPIM”), the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC and Guggenheim Distributors, LLC, affiliates of GP, SI, GFIA and GPIM.
|
|